BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38068984)

  • 21. Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.
    Manikandan M; Deva Magendhra Rao AK; Rajkumar KS; Rajaraman R; Munirajan AK
    J Oral Pathol Med; 2015 Nov; 44(10):792-800. PubMed ID: 25482863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-186-5p inhibits the progression of oral squamous cell carcinoma by targeting ITGA6 to impair the activity of the PI3K/AKT pathway.
    Chen M; Zhang J
    J Oral Pathol Med; 2022 Apr; 51(4):322-331. PubMed ID: 35201653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring miR-155-5p and miR-1246 as Diagnostic and Prognostic Markers in Oral Squamous cell carcinoma.
    Maheswari R; Urs AB; Kumar P; Koner BC; Guru SA; Rawat G
    Mol Biol Rep; 2024 Feb; 51(1):341. PubMed ID: 38400867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated microRNA-145 inhibits the development of oral squamous cell carcinoma through inactivating ERK/MAPK signaling pathway by down-regulating HOXA1.
    Ding J; Sun D; Xie P
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31138758
    [No Abstract]   [Full Text] [Related]  

  • 25. Interplay between cancer cells and M2 macrophages is necessary for miR-550a-3-5p down-regulation-mediated HPV-positive OSCC progression.
    Cao MX; Zhang WL; Yu XH; Wu JS; Qiao XW; Huang MC; Wang K; Wu JB; Tang YJ; Jiang J; Liang XH; Tang YL
    J Exp Clin Cancer Res; 2020 Jun; 39(1):102. PubMed ID: 32493454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
    Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
    Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
    [No Abstract]   [Full Text] [Related]  

  • 27. The increase of oncogenic miRNA expression in tongue carcinogenesis of a mouse model.
    Kao YY; Tu HF; Kao SY; Chang KW; Lin SC
    Oral Oncol; 2015 Dec; 51(12):1103-12. PubMed ID: 26525105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exosomal miR-146b-5p derived from cancer-associated fibroblasts promotes progression of oral squamous cell carcinoma by downregulating HIPK3.
    He L; Guo J; Fan Z; Yang S; Zhang C; Cheng B; Xia J
    Cell Signal; 2023 Jun; 106():110635. PubMed ID: 36813147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-211 Enhances the Oncogenicity of Carcinogen-Induced Oral Carcinoma by Repressing TCF12 and Increasing Antioxidant Activity.
    Chen YF; Yang CC; Kao SY; Liu CJ; Lin SC; Chang KW
    Cancer Res; 2016 Aug; 76(16):4872-86. PubMed ID: 27221705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-92a regulates oral squamous cell carcinoma (OSCC) cell growth by targeting FOXP1 expression.
    Guo J; Wen N; Yang S; Guan X; Cang S
    Biomed Pharmacother; 2018 Aug; 104():77-86. PubMed ID: 29772443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promotive effects of HOXA10 antisense RNA on the stemness of oral squamous cell carcinoma stem cells through a microRNA-29a/MCL-1/phosphatidyl inositol 3-kinase/protein kinase B axis.
    Wang D
    Arch Oral Biol; 2021 Jun; 126():105114. PubMed ID: 33831733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p.
    Li YY; Tao YW; Gao S; Li P; Zheng JM; Zhang SE; Liang J; Zhang Y
    EBioMedicine; 2018 Oct; 36():209-220. PubMed ID: 30243489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
    Lu M; Wang C; Chen W; Mao C; Wang J
    DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening and identification of miR-181a-5p in oral squamous cell carcinoma and functional verification in vivo and in vitro.
    Xu G; Yang Y; Yang J; Xiao L; Wang X; Qin L; Gao J; Xuan R; Wu X; Chen Z; Sun R; Song G
    BMC Cancer; 2023 Feb; 23(1):162. PubMed ID: 36800936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
    Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
    Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-194 regulated AGK and inhibited cell proliferation of oral squamous cell carcinoma by reducing PI3K-Akt-FoxO3a signaling.
    Chi H
    Biomed Pharmacother; 2015 Apr; 71():53-7. PubMed ID: 25960215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long noncoding RNA TFAP2A-AS1 promotes oral squamous cell carcinoma cell growth and movement via competitively binding miR-1297 and regulating TFAP2A expression.
    Yang K; Niu Y; Cui Z; Jin L; Peng S; Dong Z
    Mol Carcinog; 2022 Sep; 61(9):865-875. PubMed ID: 35730908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-340-5p affects oral squamous cell carcinoma (OSCC) cells proliferation and invasion by targeting endoplasmic reticulum stress proteins.
    Ou D; Wu Y; Zhang J; Liu J; Liu Z; Shao M; Guo X; Cui S
    Eur J Pharmacol; 2022 Apr; 920():174820. PubMed ID: 35227681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-504 functions as a tumor suppressor in oral squamous cell carcinoma through inhibiting cell proliferation, migration and invasion by targeting CDK6.
    Wang X; Chang K; Gao J; Wei J; Xu G; Xiao L; Song G
    Int J Biochem Cell Biol; 2020 Feb; 119():105663. PubMed ID: 31812760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.